KR20030019620A - Ｃｏｐｄ와 관련된 증상 악화의 감소 방법 - Google Patents

Ｃｏｐｄ와 관련된 증상 악화의 감소 방법 Download PDF

Info

Publication number
KR20030019620A
KR20030019620A KR10-2003-7001144A KR20037001144A KR20030019620A KR 20030019620 A KR20030019620 A KR 20030019620A KR 20037001144 A KR20037001144 A KR 20037001144A KR 20030019620 A KR20030019620 A KR 20030019620A
Authority
KR
South Korea
Prior art keywords
copd
patients
exacerbation
pde4
treatment
Prior art date
Application number
KR10-2003-7001144A
Other languages
English (en)
Korean (ko)
Inventor
제프리 디. 에델슨
Original Assignee
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스미스클라인 비참 코포레이션 filed Critical 스미스클라인 비참 코포레이션
Publication of KR20030019620A publication Critical patent/KR20030019620A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR10-2003-7001144A 2000-07-27 2001-07-26 Ｃｏｐｄ와 관련된 증상 악화의 감소 방법 KR20030019620A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27
US60/221,275 2000-07-27
PCT/US2001/023542 WO2002009689A1 (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with copd

Publications (1)

Publication Number Publication Date
KR20030019620A true KR20030019620A (ko) 2003-03-06

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7001144A KR20030019620A (ko) 2000-07-27 2001-07-26 Ｃｏｐｄ와 관련된 증상 악화의 감소 방법

Country Status (16)

Country Link
EP (1) EP1320361A4 (zh)
JP (1) JP2004505039A (zh)
KR (1) KR20030019620A (zh)
CN (1) CN1444476A (zh)
AR (1) AR029984A1 (zh)
AU (2) AU7902301A (zh)
BR (1) BR0112682A (zh)
CA (1) CA2417336A1 (zh)
CZ (1) CZ2003141A3 (zh)
HU (1) HUP0300685A3 (zh)
IL (1) IL153919A0 (zh)
MX (1) MXPA03000714A (zh)
NO (1) NO20030332D0 (zh)
PL (1) PL365612A1 (zh)
WO (1) WO2002009689A1 (zh)
ZA (1) ZA200300476B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012586A (ko) * 2018-07-27 2020-02-05 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
DZ3249A1 (fr) * 1999-10-29 2001-05-10 Smithkline Beecham Corp Procédé d'administration d'un inhibiteur phosphodiesterase 4

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012586A (ko) * 2018-07-27 2020-02-05 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
AR029984A1 (es) 2003-07-23
CZ2003141A3 (cs) 2004-07-14
IL153919A0 (en) 2003-07-31
EP1320361A1 (en) 2003-06-25
AU7902301A (en) 2002-02-13
HUP0300685A3 (en) 2004-10-28
NO20030332L (no) 2003-01-22
AU2001279023B2 (en) 2005-11-10
HUP0300685A2 (hu) 2003-12-29
BR0112682A (pt) 2003-06-24
CA2417336A1 (en) 2002-02-07
NO20030332D0 (no) 2003-01-22
JP2004505039A (ja) 2004-02-19
MXPA03000714A (es) 2003-06-04
ZA200300476B (en) 2004-04-23
WO2002009689A1 (en) 2002-02-07
EP1320361A4 (en) 2006-04-05
CN1444476A (zh) 2003-09-24
PL365612A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
US20060069155A1 (en) Method for reducing exacerbations associated with COPD
Zusman et al. Overall cardiovascular profile of sildenafil citrate
JP5411504B2 (ja) 薬物嗜癖および行動嗜癖を治療するためのイブジラストの使用
KR20070032619A (ko) 폐동맥 고혈압의 치료를 위한 일로프로스트의 복합 치료제
KR20030019620A (ko) Ｃｏｐｄ와 관련된 증상 악화의 감소 방법
KR20140074270A (ko) 조합 als 치료법
Lieberman et al. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
AU772909B2 (en) Method for administering a phosphodiesterase 4 inhibitor
AU2001279023A1 (en) Method for reducing exacerbations associated with COPD
US20060142308A1 (en) Synergistic combination comprising roflumilast and formoterol
WO2003024488A2 (en) Combination of a pde inhibitor and a leukotriene receptor antagonist
EP1567140B1 (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
Jenkins et al. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis
JPWO2005063253A1 (ja) アレルギー症状治療用医薬組成物
JP2021102603A (ja) 腹圧性尿失禁改善剤
JP2001089375A (ja) 感冒用組成物
JP2009256237A (ja) 固形製剤
AU2002333851A1 (en) Combination of a PDE inhibitor and a leukotriene receptor antagonist

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid